Income Statement AddLife AB

Equities

ALIF B

SE0014401378

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm Other stock markets 10:30:00 16/01/2026 pm IST			5-day change	1st Jan Change
152.10 ^SEK	-0.72%		-1.93%	-4.40%

15/01	DNB Carnegie Lowers Target Price for Addlife to 170 Kronor (204), Reiterates Hold	FW
14/01	Indecap Sverige Rises 1.55 Percent in December - Strong Performance for Boliden	FW

f86d9954a65f61f5.T44rSeo7DPv7QXsrH6poKgKIEyc68JqH2ZPu5cLUfFQ.Pe1APaFqecu8GzJhecsvc1HAexFWxPexlNuGqfuNDSIL1m0Bq144r8N2DA

Published financial data: ADDLIFE AB

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	527.33Cr	799.26Cr	908.4Cr	968.5Cr	1.03TCr
Total Revenues	527.33Cr	799.26Cr	908.4Cr	968.5Cr	1.03TCr
Cost of Goods Sold, Total	345.49Cr	513.6Cr	565.7Cr	608.5Cr	642.7Cr
Gross Profit	181.84Cr	285.66Cr	342.7Cr	360Cr	385.9Cr
Selling General & Admin Expenses, Total	113.57Cr	181.89Cr	265.6Cr	300.7Cr	308Cr
R&D Expenses	2.39Cr	3.35Cr	8.1Cr	9.7Cr	7.1Cr
Other Operating Expenses	-1.64Cr	-4.23Cr	-3.5Cr	-7.3Cr	-1.9Cr
Other Operating Expenses, Total	114.32Cr	181.01Cr	270.2Cr	303.1Cr	313.2Cr
Operating Income	68Cr	104.65Cr	72Cr	57Cr	73Cr
Interest Expense, Total	-1.58Cr	-5.61Cr	-11Cr	-27Cr	-30Cr
Interest And Investment Income	8L	9L	44Cr	90L	50L
Net Interest Expenses	-1.5Cr	-5.52Cr	33Cr	-26Cr	-29Cr
Currency Exchange Gains (Loss)	-31L	-34L	-9.4Cr	2.6Cr	-70L
Other Non Operating Income (Expenses)	-21L	-29L	-45Cr	-90L	-2.1Cr
EBT, Excl. Unusual Items	66Cr	98Cr	51Cr	32Cr	41Cr
Restructuring Charges	-	-	-	-13Cr	-1Cr
Merger & Related Restructuring Charges	-1.2Cr	-5.55Cr	-1.2Cr	-	-20L
Gain (Loss) On Sale Of Assets	37L	33L	30L	30L	60L
Other Unusual Items	1.23Cr	-56L	9.7Cr	15Cr	40L
EBT, Incl. Unusual Items	66Cr	93Cr	60Cr	34Cr	40Cr
Income Tax Expense	14Cr	21Cr	12Cr	15Cr	15Cr
Earnings From Continuing Operations	52Cr	72Cr	48Cr	19Cr	25Cr
Net Income to Company	52Cr	72Cr	48Cr	19Cr	25Cr
Minority Interest	-19L	-20L	-30L	-20L	-20L
Net Income - (IS)	52Cr	72Cr	48Cr	19Cr	25Cr
Net Income to Common Incl Extra Items	52Cr	72Cr	48Cr	19Cr	25Cr
Net Income to Common Excl. Extra Items	52Cr	72Cr	48Cr	19Cr	25Cr
Per Share Items
Net EPS - Basic	4.62	6.02	3.94	1.56	2.07
Basic EPS - Continuing Operations	4.62	6.02	3.94	1.56	2.07
Basic Weighted Average Shares Outstanding	11Cr	12Cr	12Cr	12Cr	12Cr
Net EPS - Diluted	4.6	5.99	3.93	1.56	2.06
Diluted EPS - Continuing Operations	4.6	5.99	3.93	1.56	2.06
Diluted Weighted Average Shares Outstanding	11Cr	12Cr	12Cr	12Cr	12Cr
Normalized Basic EPS	3.63	5.14	2.61	1.64	2.07
Normalized Diluted EPS	3.62	5.11	2.6	1.64	2.07
Dividend Per Share	1.5	2	1.2	0.5	0.75
Payout Ratio	10.85	25.47	50.62	76.84	24.21
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	83Cr	137.64Cr	125.9Cr	116.2Cr	131.2Cr
EBITA	78Cr	129.68Cr	110.3Cr	98Cr	112.4Cr
EBIT	68Cr	104.65Cr	72Cr	57Cr	73Cr
EBITDAR	84Cr	137.84Cr	126.1Cr	116.6Cr	131.3Cr
Effective Tax Rate - (Ratio)	21.14	22.28	19.77	43.36	37.28
Total Current Taxes	15Cr	25Cr	21Cr	18Cr	19Cr
Total Deferred Taxes	-1.21Cr	-4.03Cr	-9.2Cr	-3.6Cr	-4Cr
Normalized Net Income	41Cr	61Cr	32Cr	20Cr	25Cr
Interest on Long-Term Debt	27L	35L	50L	1.1Cr	1.6Cr
Non-Cash Pension Expense	17L	16L	10L	20L	20L
Supplemental Operating Expense Items
Selling and Marketing Expenses	86Cr	143Cr	211.3Cr	242.4Cr	248.5Cr
General and Administrative Expenses	27Cr	39Cr	54Cr	58Cr	59Cr
Research And Development Expense From Footnotes	6.6Cr	7.73Cr	13Cr	23Cr	13Cr
Net Rental Expense, Total	15L	20L	20L	40L	10L
Imputed Operating Lease Interest Expense	2L	4L	4L	16.06L	5L
Imputed Operating Lease Depreciation	12.77L	16.34L	16.34L	23.94L	5L

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	22Cr	35Cr	38Cr	27Cr	33Cr
Total Cash And Short Term Investments	22Cr	35Cr	38Cr	27Cr	33Cr
Accounts Receivable, Total	76Cr	108.88Cr	135.1Cr	148.5Cr	156.1Cr
Other Receivables	4.04Cr	7.77Cr	13Cr	12Cr	21Cr
Total Receivables	80Cr	116.65Cr	148.4Cr	160.2Cr	177.5Cr
Inventory	64Cr	118.85Cr	164.6Cr	165.3Cr	172.4Cr
Prepaid Expenses	2.2Cr	4.8Cr	6.4Cr	7.8Cr	9.6Cr
Other Current Assets, Total	1.86Cr	17L	20L	30L	30L
Total Current Assets	169.24Cr	275Cr	357.2Cr	360.8Cr	392.9Cr
Gross Property Plant And Equipment	100Cr	164.87Cr	248.1Cr	278.4Cr	310.5Cr
Accumulated Depreciation	-56Cr	-102.15Cr	-158.2Cr	-173.3Cr	-195.8Cr
Net Property Plant And Equipment	43Cr	63Cr	90Cr	105.1Cr	114.7Cr
Long-term Investments	88L	87L	1Cr	90L	2Cr
Goodwill	109.96Cr	452.78Cr	531.3Cr	530.3Cr	553.7Cr
Other Intangibles, Total	84Cr	255.9Cr	299Cr	255.3Cr	229.8Cr
Deferred Tax Assets Long-Term	50L	1.12Cr	5.1Cr	4.6Cr	1.9Cr
Deferred Charges Long-Term	6.34Cr	10Cr	14Cr	11Cr	10Cr
Other Long-Term Assets, Total	70L	74L	8.5Cr	6.6Cr	-
Total Assets	414.96Cr	1.06TCr	1.31TCr	1.27TCr	1.31TCr
Liabilities
Accounts Payable, Total	65Cr	80Cr	96Cr	98Cr	109.8Cr
Accrued Expenses, Total	21Cr	30Cr	40Cr	43Cr	46Cr
Short-term Borrowings	-	45Cr	75Cr	44Cr	21Cr
Current Portion of Long-Term Debt	47Cr	273.91Cr	174.5Cr	180.6Cr	59Cr
Current Portion of Leases	9.12Cr	12Cr	13Cr	16Cr	18Cr
Current Income Taxes Payable	8.11Cr	11Cr	7Cr	3.9Cr	6.9Cr
Unearned Revenue Current, Total	50L	8.03Cr	9Cr	7.3Cr	8.5Cr
Other Current Liabilities	24Cr	31Cr	32Cr	38Cr	50Cr
Total Current Liabilities	174.5Cr	491.21Cr	445.6Cr	430.5Cr	318.5Cr
Long-Term Debt	9.96Cr	56Cr	274.4Cr	253.9Cr	373.7Cr
Long-Term Leases	14Cr	22Cr	22Cr	35Cr	36Cr
Pension & Other Post Retirement Benefits	8.05Cr	8.15Cr	6Cr	6.4Cr	6.2Cr
Deferred Tax Liability Non Current	16Cr	49Cr	46Cr	42Cr	37Cr
Other Non Current Liabilities	3.07Cr	3.4Cr	14Cr	12Cr	3.3Cr
Total Liabilities	225.93Cr	630.48Cr	808.6Cr	778.5Cr	774.6Cr
Common Stock, Total	5.83Cr	6.24Cr	6.2Cr	6.2Cr	6.2Cr
Additional Paid In Capital	113.43Cr	265.39Cr	264.2Cr	264.2Cr	264.2Cr
Retained Earnings	74Cr	154.68Cr	178.7Cr	181.9Cr	200Cr
Comprehensive Income and Other	-4.95Cr	2.21Cr	48Cr	44Cr	60Cr
Total Common Equity	188.21Cr	428.52Cr	496.8Cr	495.8Cr	530.6Cr
Minority Interest	82L	57L	30L	20L	30L
Total Equity	189.03Cr	429.09Cr	497.1Cr	496Cr	530.9Cr
Total Liabilities And Equity	414.96Cr	1.06TCr	1.31TCr	1.27TCr	1.31TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	11Cr	12Cr	12Cr	12Cr	12Cr
ECS Total Common Shares Outstanding	11Cr	12Cr	12Cr	12Cr	12Cr
Book Value / Share	16.73	35.14	40.78	40.69	43.54
Tangible Book Value	-5.73Cr	-280.16Cr	-333.5Cr	-289.8Cr	-252.9Cr
Tangible Book Value Per Share	-0.51	-22.97	-27.37	-23.78	-20.75
Total Debt	81Cr	410.21Cr	559.1Cr	528.9Cr	507.1Cr
Net Debt	59Cr	375.68Cr	521.5Cr	501.7Cr	474Cr
Debt Equivalent of Unfunded Proj. Benefit Obligation	8.05Cr	8.15Cr	6Cr	6.4Cr	6.2Cr
Debt Equivalent Oper. Leases	1.2Cr	1.6Cr	1.6Cr	3.2Cr	80L
Minority Interest, Total (Incl. Fin. Div)	82L	57L	30L	20L	30L
Account Code - Inventory Valuation	3	3	3	3	3
Inventories - Raw Materials, Total	3.32Cr	4.33Cr	6.1Cr	5.4Cr	5.3Cr
Inventories - Work In Process, Total	1.75Cr	83L	70L	1.5Cr	1Cr
Inventories - Finished Goods, Total	59Cr	113.69Cr	157.8Cr	158.4Cr	166.1Cr
Buildings, Total	4.18Cr	4.31Cr	15Cr	15Cr	16Cr
Machinery, Total	54Cr	94Cr	160.4Cr	169.9Cr	188.2Cr
Full Time Employees	1.11T	1.8T	2.22T	2.3T	2.18T
Accumulated Allowance for Doubtful Accounts (Supple)	4.59Cr	4.5Cr	3.3Cr	3.7Cr	3.5Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	52Cr	72Cr	48Cr	19Cr	25Cr
Depreciation & Amortization - CF	14Cr	20Cr	31Cr	35Cr	37Cr
Amortization of Goodwill and Intangible Assets - (CF)	11Cr	25Cr	38Cr	41Cr	40Cr
Depreciation & Amortization, Total	25Cr	45Cr	69Cr	76Cr	77Cr
Amortization of Deferred Charges, Total - (CF)	2.03Cr	2.67Cr	3.5Cr	3.7Cr	4.1Cr
(Gain) Loss From Sale Of Asset	-37L	-33L	-20L	-30L	-60L
Asset Writedown & Restructuring Costs	-	-	-	12Cr	-
Other Operating Activities, Total	5.46Cr	-6.99Cr	-17Cr	-27Cr	-70L
Change In Accounts Receivable	-17Cr	1.83Cr	6.4Cr	-13Cr	-2.8Cr
Change In Inventories	-12Cr	5.28Cr	-8.8Cr	-3Cr	-40L
Change in Other Net Operating Assets	40Cr	-18Cr	-9.7Cr	9.5Cr	7.6Cr
Cash from Operations	95Cr	101.02Cr	91Cr	77Cr	109.5Cr
Capital Expenditure	-6.27Cr	-10Cr	-21Cr	-23Cr	-25Cr
Sale of Property, Plant, and Equipment	78L	93L	1.3Cr	2.2Cr	1.6Cr
Cash Acquisitions	-35Cr	-284.33Cr	-82Cr	-2.7Cr	-10Cr
Divestitures	-	-	-	-40L	-
Sale (Purchase) of Intangible assets	-2.87Cr	-4.25Cr	-6.8Cr	-8.2Cr	-4.7Cr
Investment in Marketable and Equity Securities, Total	-	-	-	0	-10L
Cash from Investing	-43Cr	-297.79Cr	-108.6Cr	-32Cr	-39Cr
Long-Term Debt Issued, Total	27Cr	264.94Cr	141.6Cr	17Cr	7.2Cr
Total Debt Issued	27Cr	264.94Cr	141.6Cr	17Cr	7.2Cr
Long-Term Debt Repaid, Total	-61Cr	-26Cr	-85Cr	-41Cr	-68Cr
Total Debt Repaid	-61Cr	-26Cr	-85Cr	-41Cr	-68Cr
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-1.93Cr	-	-6Cr	-	-
Common Dividends Paid	-5.62Cr	-18Cr	-24Cr	-15Cr	-6.1Cr
Common & Preferred Stock Dividends Paid	-5.62Cr	-18Cr	-24Cr	-15Cr	-6.1Cr
Other Financing Activities, Total	5.22Cr	-14Cr	-13Cr	-18Cr	-1.5Cr
Cash from Financing	-37Cr	207.09Cr	13Cr	-55Cr	-68Cr
Foreign Exchange Rate Adjustments	-3.2Cr	2.61Cr	7.4Cr	-60L	3.2Cr
Net Change in Cash	12Cr	13Cr	3.1Cr	-10Cr	5.9Cr
Supplemental Items
Cash Interest Paid	1.31Cr	5.26Cr	5.3Cr	27Cr	32Cr
Cash Income Tax Paid (Refund)	9.7Cr	25Cr	26Cr	21Cr	14Cr
Levered Free Cash Flow	67Cr	44Cr	27Cr	60Cr	83Cr
Unlevered Free Cash Flow	68Cr	48Cr	34Cr	77Cr	101.14Cr
Change In Net Working Capital	-7.23Cr	51Cr	55Cr	7.2Cr	-4.2Cr
Net Debt Issued / Repaid	-35Cr	238.98Cr	57Cr	-23Cr	-61Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	11.37	8.87	3.83	2.76	3.52
Return on Total Capital	16.65	11.8	4.78	3.42	4.41
Return On Equity %	30.87	23.32	10.43	3.87	4.95
Return on Common Equity	30.92	23.3	10.38	3.83	4.91
Margin Analysis
Gross Profit Margin %	34.48	35.74	37.73	37.17	37.52
SG&A Margin	21.54	22.76	29.24	31.05	29.94
EBITDA Margin %	15.81	17.22	13.86	12	12.76
EBITA Margin %	14.87	16.22	12.14	10.08	10.93
EBIT Margin %	12.8	13.09	7.98	5.88	7.07
Income From Continuing Operations Margin %	9.86	9.02	5.32	1.98	2.47
Net Income Margin %	9.82	8.99	5.28	1.96	2.45
Net Avail. For Common Margin %	9.82	8.99	5.28	1.96	2.45
Normalized Net Income Margin	7.73	7.68	3.5	2.06	2.45
Levered Free Cash Flow Margin	12.64	5.53	3	6.18	8.03
Unlevered Free Cash Flow Margin	12.83	5.97	3.77	7.95	9.83
Asset Turnover
Asset Turnover	1.42	1.08	0.77	0.75	0.8
Fixed Assets Turnover	13.41	15.07	11.91	9.93	9.36
Receivables Turnover (Average Receivables)	8.18	8.67	7.45	6.83	6.75
Inventory Turnover (Average Inventory)	6.33	5.62	3.99	3.69	3.81
Short Term Liquidity
Current Ratio	0.97	0.56	0.8	0.84	1.23
Quick Ratio	0.58	0.31	0.42	0.44	0.66
Operating Cash Flow to Current Liabilities	0.54	0.21	0.2	0.18	0.34
Days Sales Outstanding (Average Receivables)	44.73	42.1	49.02	53.44	54.19
Days Outstanding Inventory (Average Inventory)	57.83	64.98	91.46	98.94	96.16
Average Days Payable Outstanding	49.99	46.39	52.33	58.06	58.55
Cash Conversion Cycle (Average Days)	52.57	60.69	88.15	94.33	91.8
Long Term Solvency
Total Debt/Equity	42.63	95.6	112.47	106.63	95.52
Total Debt / Total Capital	29.89	48.88	52.94	51.6	48.85
LT Debt/Equity	12.78	18.36	59.73	58.19	77.08
Long-Term Debt / Total Capital	8.96	9.39	28.11	28.16	39.42
Total Liabilities / Total Assets	54.45	59.5	61.93	61.08	59.33
EBIT / Interest Expense	42.73	18.65	6.53	2.08	2.45
EBITDA / Interest Expense	58.77	26.71	12.73	4.86	5.04
(EBITDA - Capex) / Interest Expense	54.8	24.9	10.81	4.03	4.2
Total Debt / EBITDA	0.87	2.74	3.96	3.99	3.39
Net Debt / EBITDA	0.64	2.51	3.69	3.78	3.16
Total Debt / (EBITDA - Capex)	0.93	2.94	4.66	4.81	4.06
Net Debt / (EBITDA - Capex)	0.68	2.69	4.35	4.56	3.8
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	51.56	51.57	13.65	6.62	6.21
Gross Profit, 1 Yr. Growth %	51.76	57.09	19.95	5.05	7.19
EBITDA, 1 Yr. Growth %	165.99	65.12	-8.44	-7.7	13.01
EBITA, 1 Yr. Growth %	184.4	65.3	-14.89	-11.51	15.16
EBIT, 1 Yr. Growth %	266.96	54.99	-30.69	-21.52	27.77
Earnings From Cont. Operations, 1 Yr. Growth %	265.21	38.66	-33.01	-60.25	32.29
Net Income, 1 Yr. Growth %	268.28	38.78	-33.24	-60.42	32.63
Normalized Net Income, 1 Yr. Growth %	288.81	50.59	-48.14	-37.39	26.66
Diluted EPS Before Extra, 1 Yr. Growth %	263.85	30.32	-34.49	-60.29	32.12
Accounts Receivable, 1 Yr. Growth %	41.5	44.17	24.06	9.92	5.12
Inventory, 1 Yr. Growth %	41.79	85.65	38.44	0.43	4.3
Net Property, Plant and Equip., 1 Yr. Growth %	22.94	44.65	43.38	16.91	9.13
Total Assets, 1 Yr. Growth %	26.73	155.34	23.23	-2.39	2.43
Tangible Book Value, 1 Yr. Growth %	-75.98	4.79T	19.02	-13.1	-12.73
Common Equity, 1 Yr. Growth %	28.3	127.68	15.94	-0.2	7.02
Cash From Operations, 1 Yr. Growth %	137.29	6.33	-10	-14.96	41.66
Capital Expenditures, 1 Yr. Growth %	-4.57	61.72	110.89	6.1	10.62
Levered Free Cash Flow, 1 Yr. Growth %	257.01	-33.68	-38.06	119.62	37.85
Unlevered Free Cash Flow, 1 Yr. Growth %	249.66	-29.46	-28.03	124.95	31.41
Dividend Per Share, 1 Yr. Growth %	200	33.33	-40	-58.33	50
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	45.77	51.56	31.25	10.08	6.41
Gross Profit, 2 Yr. CAGR %	42.95	54.4	37.28	12.25	6.12
EBITDA, 2 Yr. CAGR %	82.64	109.57	22.89	-8.07	2.08
EBITA, 2 Yr. CAGR %	85.49	116.88	18.57	-13.22	0.95
EBIT, 2 Yr. CAGR %	101.98	138.48	3.62	-26.25	0.14
Earnings From Cont. Operations, 2 Yr. CAGR %	100.48	125.03	-3.6	-48.4	-27.48
Net Income, 2 Yr. CAGR %	100.12	126.07	-3.72	-48.59	-27.54
Normalized Net Income, 2 Yr. CAGR %	103.13	141.98	-11.62	-43.02	-10.95
Diluted EPS Before Extra, 2 Yr. CAGR %	85.19	117.75	-7.58	-48.99	-27.57
Accounts Receivable, 2 Yr. CAGR %	21.95	42.83	33.75	16.77	7.49
Inventory, 2 Yr. CAGR %	25.22	62.24	60.35	17.91	2.34
Net Property, Plant and Equip., 2 Yr. CAGR %	98.36	33.35	43.99	29.47	12.95
Total Assets, 2 Yr. CAGR %	24.72	79.89	77.39	9.67	-0.01
Tangible Book Value, 2 Yr. CAGR %	-65.49	242.66	662.91	1.7	-12.92
Common Equity, 2 Yr. CAGR %	42.21	70.92	62.47	7.57	3.35
Cash From Operations, 2 Yr. CAGR %	131.36	58.84	-2.19	-12.52	9.76
Capital Expenditures, 2 Yr. CAGR %	43.38	24.23	84.31	49.59	8.34
Levered Free Cash Flow, 2 Yr. CAGR %	433.78	53.88	-36.04	16.63	74
Unlevered Free Cash Flow, 2 Yr. CAGR %	402.11	57.05	-28.89	27.24	71.93
Dividend Per Share, 2 Yr. CAGR %	65.14	100	-10.56	-50	-20.94
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	31.23	47.68	37.7	22.46	8.77
Gross Profit, 3 Yr. CAGR %	29.31	47.52	41.95	25.57	10.54
EBITDA, 3 Yr. CAGR %	52.14	76.6	58.97	11.71	-1.55
EBITA, 3 Yr. CAGR %	53.45	78.53	58.75	7.55	-4.64
EBIT, 3 Yr. CAGR %	61.4	84.92	57.95	-5.54	-11.42
Earnings From Cont. Operations, 3 Yr. CAGR %	62.87	77.3	50.28	-28.25	-29.37
Net Income, 3 Yr. CAGR %	62.67	77.13	50.57	-28.41	-29.49
Normalized Net Income, 3 Yr. CAGR %	64.15	83.85	44.81	-21.22	-25.63
Diluted EPS Before Extra, 3 Yr. CAGR %	54.97	64.72	45.93	-30.26	-29.95
Accounts Receivable, 3 Yr. CAGR %	31.28	28.95	36.29	25.28	12.75
Inventory, 3 Yr. CAGR %	33.18	42.78	53.91	37.19	13.18
Net Property, Plant and Equip., 3 Yr. CAGR %	79.72	78.54	36.6	34.33	22.3
Total Assets, 3 Yr. CAGR %	29.94	58.36	58.58	45.36	7.2
Tangible Book Value, 3 Yr. CAGR %	-45.5	79.92	140.88	269.81	-3.36
Common Equity, 3 Yr. CAGR %	36.01	66.36	50.17	38.11	7.38
Cash From Operations, 3 Yr. CAGR %	65.92	78.54	31.43	-6.65	2.73
Capital Expenditures, 3 Yr. CAGR %	13.48	49.25	48	53.33	35.27
Levered Free Cash Flow, 3 Yr. CAGR %	66.86	166.36	13.46	-3.51	23.32
Unlevered Free Cash Flow, 3 Yr. CAGR %	66.13	161.02	20.92	4.39	28.62
Dividend Per Share, 3 Yr. CAGR %	39.71	53.78	33.89	-30.66	-27.89
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	32.75	31.24	31.3	24.21
Gross Profit, 5 Yr. CAGR %	-	33.63	32.44	32.25	26.35
EBITDA, 5 Yr. CAGR %	-	47.87	39.69	35.98	33.16
EBITA, 5 Yr. CAGR %	-	48.93	38.43	33.76	32.45
EBIT, 5 Yr. CAGR %	-	49.29	35.18	28.02	31.63
Earnings From Cont. Operations, 5 Yr. CAGR %	-	45.11	32.05	8.23	12.29
Net Income, 5 Yr. CAGR %	-	45.03	31.88	8	12.38
Normalized Net Income, 5 Yr. CAGR %	-	47.84	28.14	15.07	19.22
Diluted EPS Before Extra, 5 Yr. CAGR %	-	37.47	26.03	3.07	10.27
Accounts Receivable, 5 Yr. CAGR %	-	27.3	32.26	23.94	23.94
Inventory, 5 Yr. CAGR %	-	36.33	43.45	32.27	30.73
Net Property, Plant and Equip., 5 Yr. CAGR %	-	56.04	64.47	56.99	26.6
Total Assets, 5 Yr. CAGR %	-	46.38	47.17	36.72	31.86
Tangible Book Value, 5 Yr. CAGR %	-	88.28	56.62	43.22	60.35
Common Equity, 5 Yr. CAGR %	-	42.99	46.03	39.73	29.32
Cash From Operations, 5 Yr. CAGR %	-	50.1	34.31	34.21	22.29
Capital Expenditures, 5 Yr. CAGR %	-	17.08	37.78	49.27	30.64
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	13.7	91.27	34.62
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	18.31	95.66	39.2
Dividend Per Share, 5 Yr. CAGR %	-	31.95	16.89	-1.89	8.45